Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec 21;14(1):58.
doi: 10.1186/s13011-019-0245-y.

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway

Ole Jørgen Lygren  1   2 , Ronny Bjørnestad  1   2 , Else-Marie Løberg  2   3   4   5 , Martine Lepsøy Bonnier  6 , Vibeke Bråthen Buljovcic  2 , Kjell Arne Johansson  2   7 , Lars T Fadnes  8   9 ; INTRO-HCV Study Group
Collaborators, Affiliations

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway

Ole Jørgen Lygren et al. Subst Abuse Treat Prev Policy. .

Abstract

Background: For people with opioid dependence in Norway, chronic hepatitis C virus (HCV) infections contribute to high mortality and high morbidity. Around 50% of patients in medically assisted rehabilitation (MAR) have been shown to have HCV, and the current prevention and control efforts have been mostly unsuccessful. Thus, there is a need for new strategies for people-centred service delivery and innovative methods to improve health outcomes.

Methods: Over the last few years, the city of Bergen, Norway, has developed a cross-sector collaboration with substantial peer involvement in research and health provision related to substance use. User group representatives for people receiving MAR, addiction medicine health personnel, infectious disease specialists, policy makers in the municipality, low-threshold health care centres for people with substance use disorders in Bergen Municipality and researchers in the INTRO-HCV project have made concerted efforts in this regard. We will present here some of the strategies and steps we have taken.

Results: We have established an integrated HCV treatment scheme for people who inject drugs or who have opioid dependence. More than 800 persons have been tested for HCV within these frames, and more than 250 persons have been given treatment for HCV within the project. The integrated treatment of HCV is offered both in MAR outpatient clinics, municipal low-threshold healthcare centres, and local and regional prisons. The preliminary results indicate an increase in HCV treatment uptake among those receiving integrated treatment (96% initiating treatment compared to 75%). The user group organisation ProLAR Nett has established an outreach service to screen for HCV, increase awareness and reduce the proportion of people unknowingly living with HCV while informing and motivating people to receive treatment. Together with the other stake holders, peer user group, health care, research planning, concert events, and policy panels have been held.

Conclusions: Peer involvement seems to have increased testing rates for HCV and acknowledgment of its importance. This seems to have improved health care for people with opioid dependence in Bergen over the last few years, particularly relating to the treatment of HCV. These experiences might be helpful in the planning of integrated policies in other settings that seek to eliminate the HCV endemic.

Keywords: Chronic hepatitis C; Integrated health care; Opiate substitution treatment; Substance abuse treatment centers.

PubMed Disclaimer

Conflict of interest statement

The authors EML, MLB, VBB, KAJ, LTF have no competing interests. OJL and RB have received some funding from AbbVie, Gilead and MSD.

Figures

Fig. 1
Fig. 1
Photos from some of the responses mentioned in the paper including some of the newspaper stories and the outreach bus used («Hepatittbussen»)
See this image and copyright information in PMC

References

    1. Chen Y, Shiels MS, Thomas D, Freedman ND, de Gonzalez AB. Premature Mortality From Drug Overdoses: A Comparative Analysis of 13 Organisation for Economic Co-operation and Development Member Countries With High-Quality Death Certificate Data, 2001 to 2015. Ann Intern Med:2018. - PMC - PubMed
    1. Dalgard O, Jeansson S, Skaug K, Raknerud N, Bell H. Hepatitis C in the general adult population of Oslo: prevalence and clinical spectrum. Scand J Gastroenterol. 2003;38(8):864–870. doi: 10.1080/00365520310004542. - DOI - PubMed
    1. GBD 2013 Mortality and Causes of Death Collaborators: Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet 2015, 385(9963):117–171. - PMC - PubMed
    1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatol. 2013;57(4):1333–1342. doi: 10.1002/hep.26141. - DOI - PubMed
    1. World Health Organization (WHO): Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. In. Edited by Saeed Sadiq H, Malhotra B. Geneva, Switzerland; 2016: 138.

Publication types

MeSH terms

LinkOut - more resources